NCT06625138 Trial of Latex Vs Non-latex Hemorrhoid Banding
| NCT ID | NCT06625138 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huntington Memorial Hospital |
| Condition | Hemorrhoid |
| Study Type | INTERVENTIONAL |
| Enrollment | 164 participants |
| Start Date | 2024-08-30 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 164 participants in total. It began in 2024-08-30 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will involve the recruitment of adult patients with hemorrhoids for whom rubber band ligation is the recommended treatment. Patients will be randomized to receive banding with a latex band or non-latex band. Our goal will be to measure the performance of latex bands vs non-latex bands.
Eligibility Criteria
Inclusion Criteria: * Symptomatic grade 2-3 internal hemorrhoids undergoing rubber band ligation Exclusion Criteria: * Previous hemorrhoidal banding within the past year * Known latex allergy * Pregnancy * Anticoagulation use * Bleeding disorder * Portal hypertension * Inflammatory bowel disease * Immunosuppression * Functional neurologic disorder * Pelvic floor dysfunction * Any records flagged "break the glass" or "research opt out".
Contact & Investigator
Adam Truong, MD
PRINCIPAL INVESTIGATOR
Huntington Health
Frequently Asked Questions
Who can join the NCT06625138 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemorrhoid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06625138 currently recruiting?
Yes, NCT06625138 is actively recruiting participants. Contact the research team at adam.truong@huntingtonhealth.org for enrollment information.
Where is the NCT06625138 trial being conducted?
This trial is being conducted at Pasadena, United States.
Who is sponsoring the NCT06625138 clinical trial?
NCT06625138 is sponsored by Huntington Memorial Hospital. The principal investigator is Adam Truong, MD at Huntington Health. The trial plans to enroll 164 participants.